Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Denosumab × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 9 Breast 9 Plasma cell 4 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

Imatinib Mesylate 27 nilotinib 19 Cytarabine 19 Methotrexate 13 Hydroxyurea 13 Cyclophosphamide 13 Busulfan 13 Peripheral Blood Stem Cell Transplantation 11 Etoposide 11 Whole-Body Irradiation 9 ruxolitinib 8 fludarabine phosphate 8 fludarabine 8 Idarubicin 8 Radiotherapy 7 Mitoxantrone 7 Interferon-alpha 7 Daunorubicin 7 Tacrolimus 6 Mycophenolic Acid 6 bosutinib 5 asciminib 5 Melphalan 5 Cyclosporine 5 Azacitidine 5 luspatercept 4 Thioguanine 4 Dasatinib 4 thymoglobulin 3 peginterferon alfa-2b 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03401060 2024-05-03

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡